IP Verse

Product And Method For Improving Bioavailability Of Therapeutic Compounds - EP2968070

The patent EP2968070 was granted to Glanbia Nutritionals Ireland on Dec 18, 2019. The application was originally filed on Mar 17, 2014 under application number EP14762887A. The patent is currently recorded with a legal status of "Revoked".

EP2968070

GLANBIA NUTRITIONALS IRELAND
Application Number
EP14762887A
Filing Date
Mar 17, 2014
Status
Revoked
May 14, 2021
Grant Date
Dec 18, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DSM NUTRITIONAL PRODUCTSSep 18, 2020-ADMISSIBLE

Patent Citations (21) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2010099607
INTERNATIONAL-SEARCH-REPORTUS5460823
OPPOSITIONCN102512404
OPPOSITIONEP2540169
OPPOSITIONJP2009040722
OPPOSITIONUS2012070469
OPPOSITIONWO0066665
OPPOSITIONWO03030872
OPPOSITIONWO2007060177
OPPOSITIONWO2007110422
OPPOSITIONWO2008139952
OPPOSITIONWO2009101612
OPPOSITIONWO2009101613
OPPOSITIONWO2009101614
OPPOSITIONWO2014145851
SEARCHJPH092928
SEARCHUS2008026983
SEARCHUS2010099607
SEARCHUS5460823
SEARCHWO2009101614
SEARCHWO2011100983

Non-Patent Literature (NPL) Citations (21) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- HAILONG YUQINGRONG HUANG, "Investigation of the Absorption Mechanism of Solubilized Curcumin Using Caco-2 Cell Monolayers", J. Aqric. Food Chem., (20110000), vol. 59, pages 9120 - 9126-
DESCRIPTION- WAHLAND, B. et al., "Identification of permeability-related hurdles in oral delivery of curcumin in the Caco-2 cell model", European Journal of Pharmaceutics and Biopharmaceutics, (20110000), vol. 77, doi:doi:10.1016/j.ejpb.2010.12.006, pages 275 - 282, XP028132523
DESCRIPTION- SAHU, A. et al., "Fluorescence Study of the Curcumin-Casein Micelle Complexation and its Application as a Drug Nanocarrier to Cancer Cells", Biomacromolecules, (20080000), vol. 9, no. 10, doi:doi:10.1021/BM800683F, pages 2905 - 2912, XP002576834
INTERNATIONAL-SEARCH-REPORT- SAHU, A ET AL., "Fluorescence study of the curcumin- casein micelle complexation and its application as a drug nanocarrier to cancer cells", BIOMACROMOLECULES, (2008), vol. 9.10, pages 2906 - 2908, XP002576834
OPPOSITION- Alina Shapira; Yehuda G Assaraf; Dikla Epstein; Yoav D Livney, "Beta-casein Nanoparticles as an Oral Delivery System for Chemotherapeutic Drugs: Impact of Drug Structure and Properties on Co- assembly", Pharm. Res., (20100000), vol. 27, pages 2175 - 2186, XP019828051-
OPPOSITION- Mandy H. M. Leung, Takaaki Harada And Tak W. Kee, "Delivery of Curcumin and Medicinal Effects of the Copper(II)-Curcumin Complexes", Current Pharmaceutical Design, (20130000), vol. 19, pages 2070 - 2083, XP055738407-
OPPOSITION- MAARTEN ALDERLIESTEN, "Mean Particle Diameters - Part II: Standardization of Nomenclature", Part. Part. Syst. Charact., (19910000), vol. 8, pages 237 - 241, XP055277750
OPPOSITION- Ahmed O. Elzoghby, Wael M. Samy & Nazik A. Elgindy, "Novel Spray-Dried Genipin-Crosslinked Casein Nanoparticles for Prolonged Release of Alfuzosin Hydrochloride", Pharm. Res., (20130000), vol. 30, pages 512 - 522, XP055738398
OPPOSITION- M.S. LATHA et al., "Bioavailability of theophylline from glutaraldehyde cross-linked casein microspheres in rabbits following oral administration", Journal of Controlled Release, (19950000), vol. 34, doi:10.1016/0168-3659(94)00088-C, pages 1 - 7, XP000498917
OPPOSITION- YOAV D. LIVNEY, "Milk proteins as vehicles for bioactives", Current Opinion in Colloid & Interface Science, (20100000), vol. 15, doi:10.1016/j.cocis.2009.11.002, pages 73 - 83, XP026896481
OPPOSITION- Elzoghby Ahmed O; Helmy Maged W; Samy Wael M; Elgindy Nazik A, "Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: Formulation, characterization, and in vivo pharmacokinetics", European Journal of Pharmaceutics and Biopharmaceutics, (20130000), vol. 84, doi:10.1016/j.ejpb.2013.01.005, pages 487 - 496, XP028568457
OPPOSITION- Elzoghby Ahmed O; Saad Noha I; Helmy Maged W; Samy Wael M; Elgindy Nazik A, "lonically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats", European Journal of Pharmaceutics and Biopharmaceutics, (20130000), vol. 85, doi:10.1016/j.ejpb.2013.07.003, pages 444 - 451, XP028784876
OPPOSITION- EFRAT SEMO, Kesselman E; Danino E; Livney D; Y D, "Casein micelle as a natural nano-capsular vehicle for nutraceuticals", Food Hydrocolloids, (20070000), vol. 21, doi:10.1016/j.foodhyd.2006.09.006, pages 936 - 942, XP005925153
OPPOSITION- Patricia Zimet; Dina Rosenberg; Yoav D Livney, "Re-assembled casein micelles and casein nanoparticles as nano- vehicles for omega-3 polyunsaturated fatty acids", Food Hydrocolloids, (20110000), vol. 25, doi:10.1016/j.foodhyd.2010.11.025, pages 1270 - 1276, XP028163275
OPPOSITION- Ahmed O Elzoghby; Wael M Samy; Nazik A Elgindy, "Albumin-based nanoparticles as potential controlled release drug delivery systems", Journal of Controlled Release, (20120000), vol. 157, doi:10.1016/j.jconrel.2011.07.031, pages 168 - 182, XP028442118
OPPOSITION- Michal Bachar; Amitai Mandelbaum; Irina Portnaya; Hadas Perlstein; Simcha Even-Chen; Yechezkel Barenholz; Dganit Danino, "Development and characterization of a novel drug nanocarrier for oral delivery, based on self-assembled beta-casein micelles", Journal of Controlled Release, (20120000), vol. 160, doi:10.1016/j.jconrel.2012.01.004, pages 164 - 171, XP028512648
OPPOSITION- Ahmed O Elzoghby; Wael M Samy; Nazik A Elgindy, "Protein-based nanocarriers as promising drug and gene delivery systems", Journal of Controlled Release, (20120000), vol. 161, doi:10.1016/j.jconrel.2012.04.036, pages 38 - 49, XP028493059
OPPOSITION- Gunasekaran S; Ko S; Xiao L, "Use of whey proteins for encapsulation and controlled delivery applications", Journal of Food Engineering, (20070000), vol. 83, doi:10.1016/j.jfoodeng.2006.11.001, pages 31 - 40, XP002593915
OPPOSITION- Mansoore Esmaili; Mahmood Ghaffari S; Zeinab Moosavi-Movahedi; Malihe Sadat Atri; Ahmad Sharifizadeh; Mohammad Farhadi; Reza Yousefi; Jean-Marc Chobert; Thomas Haertl; Ali Akbar Moosavi-Movahedi, "Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application", LWT - Food Science and Technology, (20110000), vol. 44, doi:10.1016/j.lwt.2011.05.023, pages 2166 - 2172, XP028268005
OPPOSITION- Michal Haham, Ish-Shalom Sophia, Nodelman Marina, Duek Irit, Segal Elena, Kustanovich Marina, Livney Yoav D., "Stability and bioavailability of vitamin D nanoencapsulated in casein micelles", Food & Function, (20120000), vol. 3, pages 737 - 744, XP055738400
SEARCH- SAHU A ET AL, "Fluorescence study of the curcumin-casein micelle complexation and its application as a drug nanocarrier to cancer cells", BIOMACROMOLECULES, AMERICAN CHEMICAL SOCIETY, US, vol. 9, no. 10, doi:10.1021/BM800683F, ISSN 1525-7797, (20081001), pages 2905 - 2912, (20080912), XP002576834 [Y] 1-14 * page 2906, column 1, paragraph 0006 * * page 2906, column 2, paragraph 0011 * * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents